Facts of Autism Found in Peer-Reviewed Journals
1. Inflammation
hs-CRP inflammation levels in autistic children are extreme:
- “Normal range”: <1.0 ng/mL
- “Heart disease risk”: >3 ng/mL
- “Autoimmune disease”: 20-80 ng/mL
- Autism: 500+ ng/mL (extreme cases >1000 ng/mL)
Levels correlate with symptom severity.
2. Cerebral Blood Flow
Blood flow reductions in autistic children:
- Frontal lobes: -42.7%
- Basal nucleus: -24.9%
- Temporal lobe: -22.8%
Autistic adults previously diagnosed show even worse perfusion.
3. Intestinal Permeability
43% of autistic children (9/21) show abnormal permeability. This allows undigested food particles, toxins, and bacteria to leak into bloodstream, triggering immune response and red blood cell clumping (Rouleaux formations).
Connecting the Dots: Scientific Linkage
Key Pathophysiology Chain:
- Increased intestinal permeability →
- Immune activation →
- Red blood cell aggregation →
- Decreased cerebral blood flow
Early intervention strategy: Screen newborns via hs-CRP test (requires only finger-prick blood). Continue biannually in non-verbal children or those with developmental delays.
Autism Prevalence & Current Challenges
Current U.S. rate: 1 in 31 births. No objective diagnostic tests/treatments in standard care. FDA-approved medications only address behavioral symptoms: Risperidone (Ages 5-16) and Aripiprazole (Ages 6-17).
Proposed Diagnostic Framework
- Combine behavioral tools like M-CHAT with: hs-CRP blood test, Sedimentation rate, Lipoprotein Phospholipase A2 (LpPlA2)
- Critical need for objective screening to prevent developmental delays
Scientific References
- Intestinal permeability in children with autism
- Regional cerebral blood flow in children with ASD
- Impact of Humic Acids on Intestinal Microbiota
- Intestinal Permeability Correlates with Behavioral Severity
- Comparison of Children with ASD and Controls in Biomarkers
- Elevated Maternal CRP and Autism Risk
- Hydrogen as Novel Treatment Hypothesis
- hs-CRP as Diagnostic Tool